NASDAQ : DMAA

Drugs Made In America Acquisition Corp. — Company profile

Financials · Shell Companies · United States

Last price 10.89 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 264.38M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Company profile

Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combinations with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in New York, New York.

Details

NameDrugs Made In America Acquisition Corp.
SectorFinancials
IndustryShell Companies
Founded2024
Ipo Date2025-01-28
CeoRoger Bendelac
CountryUnited States
ExchangeNASDAQ
Fiscal YearJanuary - December
Reporting CurrencyUSD
Ipo Price10.00
IsinKYG2847J1040
CusipG2847J104
Cik2028614
Sic6770

Key executives

NameTitle
Roger BendelacChief Executive Officer

Contact

Address420 Lexington Avenue, Suite 1402, New York, New York 10170, United States
Phone646 726 7074